|Title:||Transfer factor in prevention of Burkitt's lymphoma relapses.|
De Vinci, C.
|Publisher:||Journal of Experimental Pathology|
|Citation:||Nkrumah, F. K., Pizza, G., Neequaye, J., Viza, D., De Vinci, C., & Levine, P. H. (1987). Transfer factor in prevention of Burkitt's lymphoma relapses. Journal of Experimental Pathology, 3(4), 463-469.|
|Abstract:||Twenty-two African children with endemic Burkitt's lymphoma entered a study to evaluate the possible efficacy of a transfer factor (TF) with specific activity against Eptein-Barr virus in preventing disease relapses. Five of eleven patients have so far relapsed in the non TF-treated group as against two of eleven in the TF-treated group. The patterns of relapse and observable increased disease free remission duration in the TF-treated group strongly suggest a beneficial effect particularly in the prevention of late relapses. A larger series of patients treated with this specific TF are needed to confirm these observations in endemic Burkitt's lymphoma.|
|Appears in Collections:||Noguchi Memorial Institute for Medical Research|
Items in UGSpace are protected by copyright, with all rights reserved, unless otherwise indicated.